Effect of snake venom cystatin gene on the protein expression profiles of mouse melanoma B16F1 cells

Chinese Pharmacological Bulletin

Volumn 27, Issue 6, 2011, Pages 791-797

  Qi, Yuan Lin ^a   Ji, Ming Kai ^a   Xie, Qun ^a,b   Huang, Qing Ling ^a   Lin, Jian Yin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b PUTIAN UNIVERSITY   (China)

Author keywords

Cystatin; Gene ontology; Melanoma; Mouse; Proteomics; Snake venom

Indexed keywords

CYSTATIN; CYSTEINE PROTEINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INITIATION FACTOR 5A; NUCLEOSIDE DIPHOSPHATE KINASE NM23; SNAKE VENOM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL METABOLISM; CELL NUCLEUS; DOWN REGULATION; DRUG EFFICACY; DRUG TARGETING; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 80052113374     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2011.06.013     Document Type: Article

References (17)

1. Billiard-Bourdet M, Nguyen V, Ferrerdi M, et al. Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom[J]. Biochem J, 1998, 331 (Pt1): 239-44.
2. Xie Q, Tang N, Wan R, et al. Recombinant snake venom cystatin inhibits the growth, invasion and metastasis of B16F10 cells and MHCC97H cells in vitro and in vivo[J], Toxicon, 2011, 57(5): 704-11.
3. Wan R, Song J, Zheng H Y, et al. The studies on effect of snake venom cystatin for invasion and metastasis of the human gastric carcinoma cell line[J]. Chin J Clin Oncol, 2005, 32(17): 961-5.
4. Wan R, Zheng H Y, Song J, et al. The effect of cysteine protease inhibitor of snake venom (sv-cystatin) on mouse melanoma cells invasion in vitro and in vivo[J]. Acta Anatomica Sin, 2006, 37 (6): 640-5. (Pubitemid 46139759)
5. Xie Q, Wan R, Lin X, et al. Effects of snake venom cystatin gene on gene expression profiles in mouse melanoma cell line B16F1 [J]. Chin J Cancer, 2008, 27(7): 716-22.
6. Miao L, Liu J X, Li X Z, Pan Y H. Proteomics research on myocardial tissues of Chinese experimental mini-pig model with coronary heart disease[J]. Chin Pharmacol Bull, 2009, 25(7): 880-3.
7. Song M, Li Y J, Lai G Q. A proteomic study on the insulin resistant HepG2 cell treated by Ecdysterone [J]. Chin Pharmacol Bull, 2009, 25(12): 1640-4.
8. Huang D W, Sherman B T, Lempicki R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nat Protoc, 2009, 4(1): 44-57.
9. Steeg P S, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential [J]. J Natl Cancer Inst, 1988, 80: 200-4.
10. Boissan M, Dabemat S, Peuchant E, et al. The mammalian NM23/NDPK family: from metastasis control to cilia movement [J]. Mol Cell Biochem, 2009, 329: 51-62.
11. Moissoglu K, McRoberts K S, Meier J A, et al. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of Rho GTPases[J]. Cancer Res, 2009, 69(7): 2838-44.
12. Niu H Y, Wang J H, Xu C, et al. Expression of RhoGDI2 In lung squamous carcinoma, adenocarcinom and lung cancer cell lines and its clinical significance [J]. Chin J Histochem Cytochem, 2010, 19(1): 32-7.
13. Chen G, Gharib T G, Huang C C, et al. Discordant protein and mRNA expression in lung adenocarcinomas [J]. Mol Cell Proteomics, 2002, 1: 304-13.
14. Sun W, He F C. Advances in differential proteomics techniques [J]. Chemistry, 2005, 68(6): 401-7.
15. Liu W, Zhu Y P, He F C. Integration of various 'Omics' data in biological systems [J]. Chin J Biochem Mol Biol, 2007, 23 (12): 971-6.
16. The gene ontology Consortium. The Gene Ontology in 2010: extensions and refinements[J]. Nucleic Acids Res, 2010, 38: D331-D335.
17. Wang J S, Qiu Z Y, Xia Y P, et al. Study on compared proteomics of focal cerebral ischemia-reperfusion in rats with the total saponins of rubus parviflolius L[J]. Chin Pharmacol Bull, 2009, 25(2): 201-4.